# OnCo record tropion-breast05 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/tropion-breast05/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "tropion-breast05", "NCT06103864" ;
  schema:name "TROPION-Breast05"@en ;
  schema:description "Tests whether Dato-DXd plus a PD-L1 blocker beats today's immunotherapy-chemotherapy standard."@en ;
  schema:url <https://onco.cc/trials/tropion-breast05/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06103864>, <https://doi.org/10.1177/17588359251327992> ;
  onco:status "recruiting" ;
  onco:phase "3" ;
  schema:startDate "2023-11-23" ;
  onco:cancers <https://onco.cc/cancers/tnbc/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/topoisomerase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/datopotamab-deruxtecan/>, <https://onco.cc/drugs/durvalumab/>, <https://onco.cc/drugs/pembrolizumab/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/>, <https://onco.cc/companies/daiichi-sankyo/> .